Telehealth services are becoming the “go-to” choice for many Americans, including Medicare beneficiaries. In this article, which summarizes an interview our own Jim Yocum did with Bloomberg Law, the journalist explains why CMS supports telehealth benefits as part of their Medicare strategy.

In a recent Bloomberg article, the writers show how prescription drug prices are moving up at a rate at least four times CPI inflation. Connecture data used to help construct Bloomberg’s new Drug Price Index.

A recent article from CNN highlights the obstacles many people with Type 1 diabetes face when it comes to rising drug costs (particularly insulin, in this case). Connecture’s prescription drug data was used and cited in the article.

One new idea on mitigating higher drug prices is to require the posting of costs in Rx advertising. This Kaiser Health News article provides illustrative examples of how this might look for the 10 drugs with the highest annual ad spend. Connecture data used.

Journalist Sarah Jane Tribble wrote a fascinating piece for the Washington Post that uses Connecture drug data and spotlights the Orphan Drug Korlym. This drug has a controversial origin as “the abortion pill,” but is also used to treat Cushing’s syndrome…and its price has shot up.

Fascinating Bloomberg story that leverages Connecture’s data and highlights a Chicago-based duo that’s selling a simple Rx strategy — and companies they’ve worked with have raised prices on drugs as much as 4,116%.

Earlier this month, Connecture hosted its first-ever FMO Council Meeting in its Chicago Innovation Hub. Connecture SVP and broker expert Joe Donlan writes about that experience and his three biggest takeaways from that session.

In her latest article, Bloomberg’s Rebecca Spalding discusses the role drug prices are playing in American politics. Connecture prescription drug data is featured.

Health insurance is always making headlines these days, particularly as Washington continues to debate over the ACA. But what about the non-traditional benefits that don’t get nearly as much coverage? Our own Amy Christofis explore this topic and their future.